Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1531 | 2610 | 48.3 | 94% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
578 | 3 | CHEMOKINES//CXCR4//MACROPHAGE MIGRATION INHIBITORY FACTOR | 16225 |
546 | 2 | CHEMOKINES//CXCR4//CHEMOKINE RECEPTOR | 14674 |
1531 | 1 | CXCR4//CXCL12//CXCR7 | 2610 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CXCR4 | authKW | 3278737 | 28% | 39% | 720 |
2 | CXCL12 | authKW | 1590921 | 11% | 49% | 276 |
3 | CXCR7 | authKW | 1217179 | 5% | 82% | 127 |
4 | SDF 1 | authKW | 860872 | 7% | 38% | 193 |
5 | CHEMOKINE RECEPTOR | authKW | 295601 | 8% | 12% | 205 |
6 | STROMAL CELL DERIVED FACTOR 1 | authKW | 294276 | 3% | 35% | 72 |
7 | CHEMOKINES | authKW | 203666 | 16% | 4% | 414 |
8 | SDF 1 ALPHA | authKW | 197870 | 2% | 32% | 53 |
9 | CXCR4 ANTAGONIST | authKW | 185590 | 1% | 55% | 29 |
10 | AMD3100 | authKW | 174145 | 2% | 34% | 44 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 11805 | 35% | 0% | 926 |
2 | Hematology | 2734 | 11% | 0% | 275 |
3 | Cell Biology | 1829 | 15% | 0% | 396 |
4 | Medicine, Research & Experimental | 1082 | 9% | 0% | 226 |
5 | Immunology | 880 | 10% | 0% | 274 |
6 | Cell & Tissue Engineering | 816 | 2% | 0% | 45 |
7 | Biochemistry & Molecular Biology | 407 | 15% | 0% | 386 |
8 | Pathology | 372 | 4% | 0% | 106 |
9 | Chemistry, Medicinal | 154 | 3% | 0% | 80 |
10 | Neurosciences | 85 | 6% | 0% | 159 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNITE IMMUNOL VIRALE | 33292 | 1% | 19% | 15 |
2 | PHARMACEUT RADIOCHEM | 24354 | 0% | 21% | 10 |
3 | GASTROINTESTINAL CANC SECT | 23395 | 0% | 100% | 2 |
4 | INVEST NEUROQUIM IUIN | 23395 | 0% | 100% | 2 |
5 | NEUROSCI PHARMA AB MOL PHARMACOL | 23395 | 0% | 100% | 2 |
6 | GOLDYNE SAVAD GENE THER Y | 21820 | 1% | 9% | 21 |
7 | OROMAXILLO IAL HEAD NECK SURG | 21252 | 0% | 18% | 10 |
8 | MED SYST CONTROL | 18300 | 0% | 26% | 6 |
9 | SERV INMUNOONCOL | 17543 | 0% | 50% | 3 |
10 | SERV PHARMACOL NEUROSCI | 17543 | 0% | 50% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TUMOR BIOLOGY | 2686 | 1% | 1% | 38 |
2 | ONCOLOGY REPORTS | 2111 | 2% | 0% | 43 |
3 | CLINICAL & EXPERIMENTAL METASTASIS | 2082 | 1% | 1% | 19 |
4 | MOLECULAR CANCER RESEARCH | 1998 | 1% | 1% | 18 |
5 | BLOOD | 1848 | 3% | 0% | 76 |
6 | THERANOSTICS | 1599 | 0% | 2% | 9 |
7 | STEM CELLS AND DEVELOPMENT | 1304 | 1% | 1% | 16 |
8 | MOLECULAR CANCER | 1271 | 1% | 1% | 14 |
9 | STEM CELLS | 1163 | 1% | 0% | 21 |
10 | CLINICAL CANCER RESEARCH | 1133 | 1% | 0% | 39 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CXCR4 | 3278737 | 28% | 39% | 720 | Search CXCR4 | Search CXCR4 |
2 | CXCL12 | 1590921 | 11% | 49% | 276 | Search CXCL12 | Search CXCL12 |
3 | CXCR7 | 1217179 | 5% | 82% | 127 | Search CXCR7 | Search CXCR7 |
4 | SDF 1 | 860872 | 7% | 38% | 193 | Search SDF+1 | Search SDF+1 |
5 | CHEMOKINE RECEPTOR | 295601 | 8% | 12% | 205 | Search CHEMOKINE+RECEPTOR | Search CHEMOKINE+RECEPTOR |
6 | STROMAL CELL DERIVED FACTOR 1 | 294276 | 3% | 35% | 72 | Search STROMAL+CELL+DERIVED+FACTOR+1 | Search STROMAL+CELL+DERIVED+FACTOR+1 |
7 | CHEMOKINES | 203666 | 16% | 4% | 414 | Search CHEMOKINES | Search CHEMOKINES |
8 | SDF 1 ALPHA | 197870 | 2% | 32% | 53 | Search SDF+1+ALPHA | Search SDF+1+ALPHA |
9 | CXCR4 ANTAGONIST | 185590 | 1% | 55% | 29 | Search CXCR4+ANTAGONIST | Search CXCR4+ANTAGONIST |
10 | AMD3100 | 174145 | 2% | 34% | 44 | Search AMD3100 | Search AMD3100 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | AZAD, BB , NIMMAGADDA, S , CHATTERJEE, S , (2014) THE INTRICATE ROLE OF CXCR4 IN CANCER.EMERGING APPLICATIONS OF MOLECULAR IMAGING TO ONCOLOGY. VOL. 124. ISSUE . P. 31 -82 | 190 | 72% | 39 |
2 | GUO, F , WANG, Y , LIU, J , MOK, SC , XUE, F , ZHANG, W , (2016) CXCL12/CXCR4: A SYMBIOTIC BRIDGE LINKING CANCER CELLS AND THEIR STROMAL NEIGHBORS IN ONCOGENIC COMMUNICATION NETWORKS.ONCOGENE. VOL. 35. ISSUE 7. P. 816 -826 | 98 | 60% | 16 |
3 | FURUSATO, B , MOHAMED, A , UHLEN, M , RHIM, JS , (2010) CXCR4 AND CANCER.PATHOLOGY INTERNATIONAL. VOL. 60. ISSUE 7. P. 497 -505 | 110 | 75% | 126 |
4 | PUCHERT, M , ENGELE, J , (2014) THE PECULIARITIES OF THE SDF-1/CXCL12 SYSTEM: IN SOME CELLS, CXCR4 AND CXCR7 SING SOLOS, IN OTHERS, THEY SING DUETS.CELL AND TISSUE RESEARCH. VOL. 355. ISSUE 2. P. 239 -253 | 121 | 74% | 13 |
5 | MISHAN, MA , AHMADIANKIA, N , BAHRAMI, AR , (2016) CXCR4 AND CCR7: TWO ELIGIBLE TARGETS IN TARGETED CANCER THERAPY.CELL BIOLOGY INTERNATIONAL. VOL. 40. ISSUE 9. P. 955 -967 | 114 | 79% | 0 |
6 | SHIM, H , OISHI, S , FUJII, N , (2009) CHEMOKINE RECEPTOR CXCR4 AS A THERAPEUTIC TARGET FOR NEUROECTODERMAL TUMORS.SEMINARS IN CANCER BIOLOGY. VOL. 19. ISSUE 2. P. 123 -134 | 155 | 63% | 16 |
7 | SUN, XQ , CHENG, GC , HAO, MG , ZHENG, JH , ZHOU, XM , ZHANG, JA , TAICHMAN, RS , PIENTA, KJ , WANG, JH , (2010) CXCL12/CXCR4/CXCR7 CHEMOKINE AXIS AND CANCER PROGRESSION.CANCER AND METASTASIS REVIEWS. VOL. 29. ISSUE 4. P. 709 -722 | 88 | 68% | 256 |
8 | LIEKENS, S , SCHOLS, D , HATSE, S , (2010) CXCL12-CXCR4 AXIS IN ANGIOGENESIS, METASTASIS AND STEM CELL MOBILIZATION.CURRENT PHARMACEUTICAL DESIGN. VOL. 16. ISSUE 35. P. 3903-3920 | 135 | 59% | 69 |
9 | KUIL, J , BUCKLE, T , VAN LEEUWEN, FWB , (2012) IMAGING AGENTS FOR THE CHEMOKINE RECEPTOR 4 (CXCR4).CHEMICAL SOCIETY REVIEWS. VOL. 41. ISSUE 15. P. 5239-5261 | 131 | 62% | 24 |
10 | ZHAO, HL , GUO, LY , ZHAO, H , ZHAO, JX , WENG, H , ZHAO, B , (2015) CXCR4 OVER-EXPRESSION AND SURVIVAL IN CANCER: A SYSTEM REVIEW AND META-ANALYSIS.ONCOTARGET. VOL. 6. ISSUE 7. P. 5022 -5040 | 78 | 80% | 22 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 32925 | MYELOKATHEXIS//WHIM SYNDROME//INSERM UMR S996 |
2 | 16547 | CCL20//CCR6//CCL21 |
3 | 18490 | CHEMOKINE STRUCTURE//LYMPHOTACTIN//CYTOKINE RECEPTOR INTERACTIONS |
4 | 32453 | CXCL14//DBC2//BRAK |
5 | 14765 | CXCR2//INTERLEUKIN 8//CXCL5 |
6 | 28577 | CXCL16//CXCR6//SR PSOX |
7 | 21780 | DARC//DUFFY BLOOD GROUP//DUFFY ANTIGEN |
8 | 7432 | BB 10010//CCL2//LEUKOTACTIN 1 |
9 | 14960 | CHEMOKINES//CHEMOKINE RECEPTOR//EXPT CLIN NEUROL |
10 | 772 | CCR5//CCR5 ANTAGONIST//MARAVIROC |